Scrip's Stock Tracker: March 2010
This article was originally published in Scrip
Executive Summary
Passage of the US healthcare reform in the House of Representatives on 21 March cleared one of the US stock market's biggest uncertainties out of the way, to the general benefit of drug stocks and traders. Gainers on the day included: Bristol-Myers Squibb, rising by 1.8%; Pfizer, up by 1.4%; and Merck & Co, which gained 0.6%.